SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.
SymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication of late-stage cancers, malignant pleural effusion (MPE). MPE causes signiﬁcant shortness of breath and chest pain in up to 15% of patients with cancer.
The driving force behind SymPhysis Medical is an unwavering commitment to provide independence and improved quality of life for patients with chronic conditions and those requiring palliative care.
Through clinical immersion and using a ‘needs-based’ innovation approach, we have identified limitations associated with current treatments for MPE. Through collaborating with clinicians, public health nurses, patients and carers, we aim to develop an innovative technology that improves clinical outcomes and the patient’s experience.
Professional Association Memberships
- Galway Chamber of Commerce